☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Insights+: Trends in the US FDA Oncology Approvals (2011-2021)
March 24, 2022
Pfizer’s Respiratory Syncytial Virus Vaccine (PF-06928316 or RSVpreF) Receives the US FDA’s Breakthrough Therapy Designation for R...
March 24, 2022
PharmaTher Reports Results of Ketamine in a Clinical Study for the Treatment of Parkinson’s Disease
March 24, 2022
argenx Reports Results of Vyvgart (efgartigimod alfa-fcab) in P-III (ADAPT-SC) Study for the Treatment of Generalized Myasthenia G...
March 24, 2022
Silence Therapeutics and Mallinckrodt Submit Clinical Trial Application for SLN501 to Treat Complement-Mediated Diseases
March 24, 2022
Moderna Reports Interim Results of COVID-19 Vaccine (mRNA-1273) in P-II/III (KidCOVE) Study for Children Aged 6 Months to Under 6...
March 24, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions